ABATE KRISTIN (Chief Accounting Officer) sold 1.2% of their position (265.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $1.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/22/2026ACC: 0001193125-26-019428
Officer· Chief Accounting Officer
Since Mar 2026
-265.00
Net shares
Net seller
$1.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
265.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−265.00
Price / share
$5.96
Trade value
$1.58K
% of position
1.2%
1/21/2026
22.84K→22.58K
Total
Net shares
−265.00
Net value
-$1.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | S · Sale | −265.00 | $5.96 | $1.58K | 1.2% | 22.84K | 22.58K |
| Total | −265.00 | -$1.58K | ||||||
Derivative Transactions0
No derivative transactions reported